MENU
QNTM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Quantum Biopharma (QNTM) Ownership - Who owns Quantum Biopharma?

Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
64.16M
P/E Ratio
N/A
Total Cash
1.53M
Projected Growth
N/A
Total Debt
2.27M
Revenue
N/A
Risk (Beta)
0.44
Dividend Yield
N/A
Total Cash/Share
0.40
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

QNTM
Capitalization
64.2M
P/E Ratio
N/A
Risk (Beta)
0.44
Dividend Yield
N/A
Total Cash
1.53M
Total Cash/Share
0.40
Total Debt
2.27M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
3.76M
P/B Ratio
16.98
Cash Flow
N/A
Earnings
-11.4
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
160M
Current Ratio
0.78
Current Revenue Per Employee
8844.20
Dividends Per Share - Security
N/A
EBITDA
-26.86M
Float
N/A
Float - Current
N/A
Gross Income Margin
-631.42
Revenue To Assets
-176.91
Shares Held By Institutions
925K
Shares Outstanding - Current
3.82M
Total Liabilities
13.2M
Total Volume MTD
N/A
Value
-1
Gain YTD
344.293
View a ticker or compare two or three
QNTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

a company, which engages in the production and processing of hydroponic indoor cannabis.

Industry Biotechnology

Profile
Fundamentals
Details